GEM Premier 5000 Class II Device Recall Z-1539-2026
Summary
The FDA has issued a Class II device recall (Z-1539-2026) for the GEM Premier 5000, Model No. 00055430010, due to an increased incidence of 'Process Control Solution Not Detected' errors. This recall affects worldwide distribution, including the US.
What changed
The FDA has initiated a Class II device recall (Z-1539-2026) for the GEM Premier 5000, Model No. 00055430010, manufactured by Instrumentation Laboratory. The recall is prompted by confirmed customer complaints indicating an increased incidence of 'Process Control Solution Not Detected' (PCSND) errors during warm-up, which can lead to GEM PAK ejection and require re-insertion. The device has been distributed worldwide, including nationwide in the US and in several other countries.
Healthcare providers and facilities using the GEM Premier 5000 should be aware of this recall and the potential for PCSND errors. While the document does not specify immediate actions beyond acknowledging the ongoing recall, users should monitor communications from Instrumentation Laboratory and the FDA regarding any corrective actions or updated guidance. Non-compliance with recall procedures or continued use of a malfunctioning device could pose risks to patient care and diagnostic accuracy.
What to do next
- Review FDA recall notice Z-1539-2026 for GEM Premier 5000
- Monitor communications from Instrumentation Laboratory regarding corrective actions
- Assess potential impact of PCSND errors on patient care and diagnostic accuracy
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1539-2026 · 20260318 · Ongoing
Product
GEM Premier 5000; Model No. 00055430010.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.